133 related articles for article (PubMed ID: 34860476)
1. Predicting drug-drug interactions by electrochemically driven cytochrome P450 3A4 reactions.
Shumyantseva VV; Koroleva PI; Bulko TV; Sergeev GV; Usanov SA
Drug Metab Pers Ther; 2022 Sep; 37(3):241-248. PubMed ID: 34860476
[TBL] [Abstract][Full Text] [Related]
2. No effect of lipoic acid on catalytic activity of cytochrome P450 3A4.
Makhova AA; Shikh EV; Bulko TV; Gilep AA; Usanov SA; Shumyantseva VV
Drug Metab Pers Ther; 2020 Jul; 35(3):. PubMed ID: 32712589
[TBL] [Abstract][Full Text] [Related]
3. Drug-drug interactions and cooperative effects detected in electrochemically driven human cytochrome P450 3A4.
Sadeghi SJ; Ferrero S; Di Nardo G; Gilardi G
Bioelectrochemistry; 2012 Aug; 86():87-91. PubMed ID: 22480862
[TBL] [Abstract][Full Text] [Related]
4. Approaches for increasing the electrocatalitic efficiency of cytochrome P450 3A4.
Shumyantseva VV; Koroleva PI; Bulko TV; Shkel TV; Gilep AA; Veselovsky AV
Bioelectrochemistry; 2023 Feb; 149():108277. PubMed ID: 36198256
[TBL] [Abstract][Full Text] [Related]
5. [Modeling of drug-drug interactions between omeprazole and erythromycin with cytochrome P450 3A4 in vitro assay].
Koroleva PI; Kuzikov AV; Masamrekh RA; Filimonov DA; Dmitriev AV; Zaviyalova MG; Rikova SM; Shich EV; Makhova AA; Bulko TV; Gilep AA; Shumyantseva VV
Biomed Khim; 2020 May; 66(3):241-249. PubMed ID: 32588830
[TBL] [Abstract][Full Text] [Related]
6. Taurine modulates catalytic activity of cytochrome P450 3A4.
Shumyantseva VV; Makhova AA; Bulko TV; Bernhardt R; Kuzikov AV; Shich EV; Kukes VG; Archakov AI
Biochemistry (Mosc); 2015 Mar; 80(3):366-73. PubMed ID: 25761690
[TBL] [Abstract][Full Text] [Related]
7. [Electroanalytical and electrocatalytical characteristics of cytochrome P450 3A4 using electrodes modified with nanocomposite carbon nanomaterials].
Kuzikov AV; Bulko TV; Koroleva PI; Masamrekh RA; Babkina SS; Gilep AA; Shumyantseva VV
Biomed Khim; 2020 Jan; 66(1):64-70. PubMed ID: 32116227
[TBL] [Abstract][Full Text] [Related]
8. [The influence of vitamin B group on monooxygenase activity of cytochrome P450 3A4: pharmacokinetics and electro analysis of catalytic properties].
Shumiantseva VV; Shikh EV; Makhova AA; Bylko TV; Kukes VG; Sizova OS; Ramenskaia GV; Usanov SA; Archakov AI
Biomed Khim; 2011; 57(3):343-54. PubMed ID: 21863748
[TBL] [Abstract][Full Text] [Related]
9. Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5.
Yamazaki H; Johnson WW; Ueng YF; Shimada T; Guengerich FP
J Biol Chem; 1996 Nov; 271(44):27438-44. PubMed ID: 8910324
[TBL] [Abstract][Full Text] [Related]
10. The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions.
Kharasch ED; Russell M; Mautz D; Thummel KE; Kunze KL; Bowdle A; Cox K
Anesthesiology; 1997 Jul; 87(1):36-50. PubMed ID: 9232132
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of distinct ligand binding sites for cytochrome P450 3A4.
Hosea NA; Miller GP; Guengerich FP
Biochemistry; 2000 May; 39(20):5929-39. PubMed ID: 10821664
[TBL] [Abstract][Full Text] [Related]
12. Electron transfer properties and catalytic competence of cytochrome b5 in the fusion protein Hmwb5-EGFP in reactions catalyzed by cytochrome P450 3A4.
Yantsevich AV; Gilep AA; Usanov SA
Biochemistry (Mosc); 2009 Aug; 74(8):862-73. PubMed ID: 19817686
[TBL] [Abstract][Full Text] [Related]
13. Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics.
Gandhi Y; Eley T; Fura A; Li W; Bertz RJ; Garimella T
Clin Pharmacokinet; 2018 Aug; 57(8):911-928. PubMed ID: 29353349
[TBL] [Abstract][Full Text] [Related]
14. Influence of inter-domain dynamics and surrounding environment flexibility on the direct electrochemistry and electrocatalysis of self-sufficient cytochrome P450 3A4-BMR chimeras.
Castrignanò S; Di Nardo G; Sadeghi SJ; Gilardi G
J Inorg Biochem; 2018 Nov; 188():9-17. PubMed ID: 30098472
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of cytochrome P450 reactions by apo-cytochrome b5: evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5 or heme oxygenase.
Yamazaki H; Shimada T; Martin MV; Guengerich FP
J Biol Chem; 2001 Aug; 276(33):30885-91. PubMed ID: 11413149
[TBL] [Abstract][Full Text] [Related]
16. [Role of antioxidants in electro catalytic activity of cytochrome P450 3A4].
Shumiantseva VV; Makhova AA; Bulko TV; Shikh EV; Kukes VG; Usanov SA; Archakov AI
Biomed Khim; 2014; 60(2):224-34. PubMed ID: 24837311
[TBL] [Abstract][Full Text] [Related]
17. Current Approaches for Investigating and Predicting Cytochrome P450 3A4-Ligand Interactions.
Sevrioukova IF; Poulos TL
Adv Exp Med Biol; 2015; 851():83-105. PubMed ID: 26002732
[TBL] [Abstract][Full Text] [Related]
18. Increasing the Efficiency of Cytochrome P450 3A4 Electrocatalysis Using Electrode Modification with Spatially Ordered Anodic Aluminum Oxide-Based Nanostructures for Investigation of Metabolic Transformations of Drugs.
Shumyantseva VV; Koroleva PI; Gilep AA; Napolskii KS; Ivanov YD; Kanashenko SL; Archakov AI
Dokl Biochem Biophys; 2022 Oct; 506(1):215-219. PubMed ID: 36303055
[TBL] [Abstract][Full Text] [Related]
19. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.
Zhou SF
Curr Drug Metab; 2008 May; 9(4):310-22. PubMed ID: 18473749
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug.
Lin HL; Zhang H; Medower C; Hollenberg PF; Johnson WW
Drug Metab Dispos; 2011 Feb; 39(2):345-50. PubMed ID: 21068193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
